Last reviewed · How we verify

NCT04335981

Determining Swallow Outcomes in Head & Neck Lymphedema Subjects Receiving Early Intervention With Pneumatic Compression

Terminated NA Last updated 17 November 2022
What this trial tests

NA trial testing FT-CC and Swallow Exercises in Head and Neck Lymphedema in 22 participants. Terminated before completion.

Timeline
24 September 2020
Primary endpoint
1 October 2022
1 October 2022

Quick facts

Lead sponsorTactile Medical
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingsingle
Primary purposetreatment
Enrollment22
Start date24 September 2020
Primary completion1 October 2022
Estimated completion1 October 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Tactile Medical — full company profile →

Who can join

18 and older, any sex, with Head and Neck Lymphedema. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of the study is to assess the effect early pneumatic compression (prior to confirming cancer-free status via PET or CT imaging) has on swallow outcomes, positron emission tomography (PET) measurements, function, and complication rate post-radiotherapy in subjects treated for oropharyngeal cancer.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Tactile Medical trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04335981.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing